Article metrics

Download PDFPDF
Extended report
A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE)

 

Online download statistics by month:

Online download statistics by month: June 2015 to September 2020

AbstractFullPdf
Jun 20151639118276
Jul 20153615772
Aug 20151785160
Sep 20151585742
Oct 2015914226
Nov 20151273543
Dec 201566960167
Jan 201656662129
Feb 20162834658
Mar 20162204963
Apr 20162374654
May 20161725163
Jun 20161594735
Jul 20161242725
Aug 20161272331
Sep 20161474041
Oct 20161294036
Nov 20161205047
Dec 201613341104
Jan 20171264035
Feb 20171785833
Mar 20171387228
Apr 20171404530
May 2017966328
Jun 20171344025
Jul 20172072224
Aug 20172012926
Sep 20171903820
Oct 20172392617
Nov 20172583020
Dec 20172493012
Jan 20182673229
Feb 20182423024
Mar 20182453920
Apr 20183064717
May 20182443724
Jun 20182403420
Jul 2018232219
Aug 20181944416
Sep 20181903918
Oct 20181822112
Nov 20181782722
Dec 201816888
Jan 20191483026
Feb 20191652111
Mar 20191863417
Apr 2019157169
May 20191552515
Jun 20191221912
Jul 20191792113
Aug 20191311510
Sep 20191172511
Oct 20191132221
Nov 20191712622
Dec 20192994723
Jan 20201473424
Feb 2020161217
Mar 2020135288
Apr 20201442914
May 20201422110
Jun 20201662412
Jul 2020146357
Aug 2020124259
Sep 2020184258
Total1377623572178